7th Trends in Head and Neck Oncology
November 7 - November 9
t is with great pleasure that we invite you to the 7th Trends in Head & Neck Oncology (THNO-7) to be held in Athens, Greece, November 7-9, 2019. This meeting will offer you up-to-date information on many aspects of head & neck cancer translated to daily practice. With a wealth of exciting data emerging in this rapidly evolving field the 7th THNO meeting will review the state-of-the-art knowledge with emphasis on multidisciplinary decision making and management of head and neck cancer, with at the same time giving ample time to discuss several translational research issues, the importance of biomarkers in different disease and treatment settings, including immune modulatory treatments, new and innovative treatment approaches in squamous cell head and neck cancer, including targeted and immunotherapy, and including the applicability of neoadjuvant and adjuvant treatments in these approaches, highlighting optimization of standard treatments in the primary and recurrent disease setting and how to optimize supportive measures, how to deal with rare head and neck tumors in the most optimal fashion and what progress has been seen in the treatment of nasopharynx cancer, and whether precision medicine is at our doorstep. All disciplines involved in the treatment of head & neck cancer will be represented in integrated sessions. The translation to daily practice will be highlighted by interactive clinical case discussions facilitated by panels.
The 7th-THNO is designed for medical oncologists, surgeons, radiation oncologists, otolaryngologists, and other medical professionals involved in the treatment of patients with head and neck cancer.
The 7th-THNO will offer excellent science and medicine in the beautiful city of Athens.